|
Market Closed -
Japan Exchange
07:30:00 09/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,237.00 JPY | -1.91% |
|
-6.38% | +6.88% |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 09-01 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
| Market Cap | 4,089B 26.52B 22.8B 21.45B 19.57B 36.53B 2,514B 36.72B 254B 98.33B 1,285B 99.58B 97.4B | P/E 2027 * |
11x | P/E 2028 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4,030B 26.13B 22.47B 21.14B 19.29B 36B 2,478B 36.19B 250B 96.9B 1,266B 98.13B 95.99B | EV / Sales 2027 * |
1.73x | EV / Sales 2028 * | 1.67x |
| Free-Float |
98.88% | Yield 2027 * |
3.52% | Yield 2028 * | 3.65% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 4503 | Delayed | |
OTC Markets
| ALPMF | Delayed | |
|
Tradegate
| YPH | Real-time | |
|
Boerse Muenchen
| YPH | Real-time | |
|
Deutsche Boerse AG
| YPH | Delayed | |
|
Börse Stuttgart
| YPH | Delayed |
Last Transcript : Astellas Pharma Inc.
| 1 day | -1.91% | ||
| 1 week | -6.38% | ||
| Current month | -5.67% | ||
| 1 month | -5.33% | ||
| 3 months | +4.31% | ||
| 6 months | -5.61% | ||
| Current year | +6.88% |
| 1 week | 2,233 |  | 2,425.5 |
| 1 month | 2,233 | | 2,455 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,557.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 64 | 09/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 31/10/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 09/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 64 | 31/05/2019 |
| Director/Board Member | 59 | 31/05/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.91% | -6.38% | +31.98% | +2.40% | 26.52B | |
| -2.21% | -3.11% | +52.16% | +91.64% | 1,002B | |
| -2.22% | -0.76% | +51.08% | +67.61% | 649B | |
| -2.99% | -4.31% | +18.59% | +66.94% | 440B | |
| -0.14% | -0.09% | +29.37% | +37.42% | 346B | |
| -0.87% | -15.78% | +8.37% | +25.24% | 263B | |
| -0.39% | -1.27% | -1.27% | +12.59% | 250B | |
| -10.08% | -10.26% | +40.32% | +51.55% | 213B | |
| -0.56% | -4.14% | -14.63% | -57.72% | 201B | |
| -2.88% | -2.19% | +26.54% | +92.95% | 182B | |
| Average | -2.12% | -2.41% | +24.25% | +39.06% | 357.02B | |
| Weighted average by Cap. | -1.36% | -2.41% | +32.74% | +57.18% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,329B 15.1B 12.99B 12.22B 11.15B 20.81B 1,432B 20.91B 145B 56B 732B 56.71B 55.48B | 2,155B 13.98B 12.02B 11.31B 10.32B 19.25B 1,325B 19.35B 134B 51.82B 677B 52.48B 51.34B |
| Net income | 356B 2.31B 1.98B 1.87B 1.7B 3.18B 219B 3.19B 22.11B 8.56B 112B 8.66B 8.48B | 333B 2.16B 1.85B 1.74B 1.59B 2.97B 204B 2.99B 20.67B 8B 104B 8.1B 7.92B |
| Net Debt | -59.18B -384M -330M -310M -283M -529M -36.38B -531M -3.68B -1.42B -18.6B -1.44B -1.41B | -481B -3.12B -2.68B -2.52B -2.3B -4.29B -296B -4.32B -29.87B -11.56B -151B -11.7B -11.45B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | JP¥2,237.00 | -1.91% | 6,209,400 |
| 08/09/26 | JP¥2,280.50 | -0.98% | 3,779,100 |
| 07/09/26 | JP¥2,303.00 | -2.23% | 3,348,800 |
| 04/09/26 | JP¥2,355.50 | -2.54% | 5,484,800 |
| 03/09/26 | JP¥2,417.00 | +1.15% | 4,891,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
